Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.

Should pharmacologic treatment of type 2 diabetes start with combination therapy or metformin monotherapy, adding other agents over time? This question was debated at the recent American Diabetes ...

Abbisko will lead the study, with both companies jointly sharing clinical trial responsibilities.

A Monash University-led study has found that an unusual pairing of two commonly used antibiotics can kill and stop the spread ...

A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...

Nivolumab plus ipilimumab significantly improves OS and PFS in NSCLC compared to chemotherapy, with a 30% reduction in death risk and no significant heterogeneity observed. Amivantamab plus lazertinib ...

The role of combination therapy is explored for the treatment of COPD. Jeffrey D. Dunn, PharmD, MBA: Let’s discuss guideline-based disease management. I’m going to address this first question to Rey.

Abbisko Therapeutics has entered into a strategic collaboration agreement with AstraZeneca (AZN) to jointly advance the clinical development of a novel IO-TKI combination therapy for non-small cell ...

Share on Pinterest A new combination therapy for prostate cancer shows promise in clinical trials. Image credit: 1shot Production/Getty Images. A multinational, phase 3 clinical trial – TALAPRO-2 – ...